NET Theranostics: Only the Beginning

Neuroendocrine Tumor (NET) Theranostics: Only the Beginning
ACNM/SNMMI Joint Webinar

Gary Ulaner, MD, PhD, FACNM; Katherine Zukotynski, BASc, MD, PhD, P.Eng; Twyla Bartel, DO, MBA, FACNM, FSNMMI

Ashwin Parihar, MBBS, MD       

Lisa Bodei, MD, PhD

Memorial Sloan Kettering Cancer Center

Course Summary
Neuroendocrine tumors (NET) theranostics is a growing field of nuclear medicine with an increasing array of imaging and therapy agents.  This webinar will review basic mechanisms and clinical application of NET theranostics.  The target audience will be  nuclear medicine physicians and radiologists.  The course would provide expertise in the proper use of NET theranostics for webinar attendees.  The expected outcomes are that attendees will better understand the mechanisms and applications of NET theranostics.

Course Objectives

1. Discuss the mechanisms of NET theranostics

2. Discuss appropriate clinical indications for NET theranostics

3. Improve interpretation of NET theranostic studies


CE Information
CE Credit applications for physicians, pharmacists, physicists and technologists are pending. Check back for updates regarding CE Credit status.

9/20/2022 12:00 PM - 1:00 PM

Register for Another Webinar

Sign In to Register